NCT03596866 2025-09-12
ALTA-3
Takeda
Phase 3 Completed
Clinical Trials
3 trialsNCT02075840 2025-07-25
ALEX
Hoffmann-La Roche
Phase 3 Completed
NCT02604342 2019-10-29
Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib
Hoffmann-La Roche
Phase 3 Completed